Sep 8, 2026 · 5 min
Drug trial setback rattles Amgen as Oracle and Bloom Energy rise
Amgen Tumbles, Oracle Rises, Bloom Energy Gains on Upside From S&P 500 Inclusion
The episode connects immediate stock catalysts with a broader question about how technology and long-term planning can shape fast-growing cities.
- 1Amgen falls after disappointing heart-drug trial news involving Novartis.
- 2Oracle rises ahead of quarterly earnings, while Bloom Energy gains on planned S&P 500 inclusion.
- 3Smart-city planning pairs AI and innovative infrastructure with Dubai’s response to rapid population growth.
Don't miss
The episode pivots from Amgen’s trial-driven decline and other stock catalysts to Dubai’s long-term response to rapid population growth.
The brief
The episode opens on rapid urbanization, asking how cities can become smarter through evolving infrastructure and long-term blueprints.
The market roundup tracks Amgen’s decline after disappointing heart-drug trial news from Novartis, while Oracle rises ahead of quarterly earnings.
Bloom Energy gains after its planned addition to the S&P 500, showing how a major index change can become a near-term stock catalyst.
The discussion then shifts from individual companies to smart cities, examining how AI and innovative infrastructure could help manage rapid urban growth.
Dubai serves as the key example of long-term urban planning, linking population growth to the challenge of building adaptable city systems.
What was said on this episode
4 statements · 4 positive
Bloom Energy systems are in high demand because of data center growth.
“their systems are in high demand due to data center growth”
Listen at 2:57
AI will compress processes and increase speed in smart-city systems.
“AI will allow in the smart city space to compress a lot of things. The speed will change.”
Listen at 3:46
Dubai responded very well to its sudden population increase.
“they reacted very well to it”
Listen at 4:13
Dubai has a long-term urban planning vision.
“They have a long term urban planning vision”
Listen at 4:14
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Amgen
Bloomberg: Business News DailyBooks & mentions
Listen to the full episode and explore every guest, topic, and moment on PodLume.